Analyst firms · Raymond James · PRQR

Raymond James PRQR price target and rating history

ProQR Therapeutics N.V. (PRQR) · Health Care

Raymond James rates ProQR Therapeutics N.V. (PRQR) Strong Buy with a $14 price target, as of its latest action on Oct 29, 2024. It has published 4 rating actions on PRQR since February 2022, including 1 upgrade and 2 downgrades.

Current rating
Strong Buy
Price target
$14
Median target, all firms
Too few
Actions on PRQR
4

Raymond James price target on PRQR

$19$17$142023202420252026
Raymond James price target on PRQR, each point a stated target, February 2022 to October 2024.

Every Raymond James rating on PRQR

How other firms rate PRQR

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BofA SecuritiesBuy$8Aug 20, 2026
OppenheimerOutperform$9Mar 12, 2026

Questions about Raymond James and PRQR

What is Raymond James's price target for PRQR?
Raymond James's latest stated price target for ProQR Therapeutics N.V. (PRQR) is $14, from its action on Oct 29, 2024.
What is Raymond James's rating on PRQR?
Raymond James rates PRQR Strong Buy, a bullish rating, as of Oct 29, 2024.
When did Raymond James last change its view on PRQR?
On Oct 29, 2024, Raymond James upgrades to Strong Buy from Outperform, price target $6 to $14.

More PRQR rating histories

All Raymond James ratingsPRQR news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.